Debate of the Decade: RCTs in the Era of Precision Oncology
How do you design clinical trials in the era of precision oncology? Are prospective randomized controlled trials necessary anymore? Drs. Ray Kurzrock, Vivek Subbiah, and Christopher Booth join Dr. Chadi Nabhan to answer these important questions.
A First-of-its-Kind Machine Learning Model to Flag, Screen People for Elevated Lipoprotein(a)
POD1UM-303: Retifanlimab Plus Chemotherapy Improves PFS in Metastatic Squamous Cell Carcinoma of the Anal Canal
RAMTAS: Ramucirumab Plus TAS102 Shows Survival Benefit in Specific Subgroups of Metastatic Colorectal Cancer